(PV or PhV), meaning of which are, pharmakon (Greek for drug) and vigilare (Latin
for to keep watch), also known as Drug Safety, as per WHO it is defined as the science
and activities relating to the detection, assessment, understanding and prevention
of adverse effects or any other drug-related problem. Together with the WHO Collaborating
Centre for International Drug Monitoring, Uppsala, WHO promotes PV at the country
level. At the end of 2010, 134 countries were part of the WHO PV Programme. The
aims of PV are to enhance patient care and patient safety in relation to the use
of medicines; and to support public health programmes by providing reliable, balanced
information for the effective assessment of the risk-benefit profile of medicines.
Sensing the ethical need towards our consumer – KHPL has since 2009 started building up of Pharmacovigilance cell and expanding its network.
Agroup of trained specialists, backed up byequally trained associates take up the responsibilities of looking after the PV cell.
To encourage people and doctors to report cases of adverse events, we have a simple online form, where necessary fields are marked and can be easily filled up and submitted to our organization.
There is constant endeavour and programme in place to upgrade and update the activities to be in sync with the international standards.